Status:
UNKNOWN
Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer
Lead Sponsor:
University of Vienna
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this trial is to assess PD1-lymphocytes in bronchoalveolar lavage in patients with lung cancer, ILD and asthma.
Detailed Description
In this trial, 20 patients with lung cancer, 10 patients with asthma and 10 patients with interstitial lung disease who have to undergo bronchocospy for medical reasons are enrolled. In each patient, ...
Eligibility Criteria
Inclusion
- age \>18 years
- patients with lung cancer, asthma or ILD and indication for bronchoscopy for medical reasons
- Ability to provide informed consent
Exclusion
- acute excacerbation in patients with asthma or ILD
- endoluminal tumor growth or penumonia in patients with lung cancer
Key Trial Info
Start Date :
March 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04827667
Start Date
March 18 2021
End Date
December 31 2021
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090